subtraction. The full-length 3155 bp cDNA sequence Simmons, 1993) , a DC/macrophages marker, followed by the human LAMP-1 (23%) and LAMP-2 (21%) (Fukuda was obtained by RACE: it contains a 5Ј untranslated sequence (nt 1-42), a 1248 bp open reading frame (nt et al., 1988) (Figure 1B) . A phylogenic tree ( Figure 2A ) illustrates the conservation of amino acid sequences of 43-1290) starting with a methionine codon situated in a consensus Kozak sequence, a 3Ј untranslated sequence the different LAMP proteins between different species. The intraluminal portion of the LAMP proteins is made of 1865 nucleotides (nt 1291-3155), and a polyadenylation signal AATAAA at position 3138 followed by a of two domains separated by a serine/proline-rich hinge region. Each domain of LAMP-1 and LAMP-2 contains poly(A) tail. The predicted polypeptide sequence of 416 amino acids has the typical features of a type I integral four cysteines that form two disulfide bridges. In contrast, only the membrane-proximal domains (domain II) membrane protein. It has a presumptive amino-terminal signal peptide of 21 residues, followed by a long extraof CD68 and DC-LAMP contain four cysteines and probably two disulfide bounds (Figures 1B and 2B) . Separate cellular domain (381 residues), a hydrophobic transmembrane domain (25 residues), and a short cytoamino acid alignments of domain I (membrane distal domain) or domain II showed that DC-LAMP shares 28% plasmic domain (10 residues). The sequence indicates that there are seven potential N-glycosylation sites (Asnand 31% identity, respectively, with CD68, 18% and 27% with LAMP-1, and 18% and 25% with LAMP-2. X-Ser/Thr) and several putative O-glycosylation sites (stretches of proline, serine, and threonine) ( Figure 1A) . Therefore, LAMP domain II regions are more conserved among LAMP family members than domain I regions. The DC-LAMP gene was mapped by in situ hybridization, using a fluorescent probe, on the 3q26.3-q27 bands Domain I of DC-LAMP and CD68 has several serine, threonine, and proline residues and therefore could of the long arm of chromosome 3 (Mattei et al., 1990) . Sequence comparison with the EMBL databases rebe considered as a mucin-like protein covered with O-linked glycans (Holness and Simmons, 1993) . Furthervealed homology with lysosomal glycoproteins from the LAMP family and, therefore, E02B02 was named DCmore, DC-LAMP has the short cytoplasmic tail with a glycine-tyrosine motif, which characterizes all known LAMP. The predicted amino acid sequence showed the closest homology (29%) with human CD68 (Holness and LAMP family members. Thus, by the search for novel DC molecules, we identifreshly isolated cells, DC-LAMP was only present in resting or PMA-ionomycin activated DC, but not in activated fied a member of the lysosome-associated membrane glycoprotein similar to CD68. monocytes, T cells, granulocytes, PBL and B cells (Figure 3B) . Identical results were obtained by RT-PCR with the same cell lines and the cells isolated ex vivo (data not DC-LAMP mRNA Is Specifically Expressed in DC and Is Up-Regulated after shown), therefore confirming the restriction of cellular distribution to DC. Semiquantitative RT-PCR was next DC Activation or Maturation When expression of DC-LAMP mRNA was studied in used to follow DC-LAMP gene transcription. During the culture of CD34 ϩ human cord blood progenitors in the normal human tissues, a strong single band of 3.2 kb was detected by Northern blot in appendix, thymus, presence of GM-CSF and TNF␣, DC-LAMP mRNA was hardly detected at day 6, but abundant at day 12. Further lymph node, and lung (adult and fetal), and a much weaker signal was found in spleen ( Figure 3C ; data not up-regulation was observed after triggering final maturation of the DC by 4 days of coculture with hCD40L-shown). No messenger was observed in bone marrow, pancreas, placenta, brain, heart, or peripheral blood leutransfected L cells ( Figure 3D ). Similarly, while monocytes do not express a detectable amount of DC-LAMP kocytes. When cell lines were analyzed, DC-LAMP was abundant in DC, scarce in PMA-ionomycin activated mRNA, a faint band could be amplified after 6 days of culture in the presence of GM-CSF and IL-4. Again, Jurkat T cells and JY lymphoblastoid B cells, and absent in myelo-erythrocytic TF1 cells, kidney carcinoma CHA following activation of these monocyte-derived DC through CD40, the level of mRNA sharply increased cells, and lung fibroblast MRC5 cells ( Figure 3A ). Among (red) showed that DC-LAMP is present from day 12 and proshowed that the DC-LAMP ϩ cells (blue) are large, intergressively increases up to day 14 ( Figure 5A ). Of note, digitated cells exclusively localized in the T cell areas, DC-LAMP up-regulation coincides with the highest level but not in B cell follicles (Figure 4Aa ). Likewise, on of surface HLA class I and II, CD83, CD80, and CD86 that spleen, lymph node, and medulla of thymus tissue seccharacterizes mature DC ( Figure 5A ; data not shown). (Figure 4Bc) . Interestingly, none of the CD68 ϩ cells (red), ures 5B and 5C). As shown in Figure 5C , DC-LAMP appears rapidly after LPS activation of monocyte-derived including the tingible body macrophages and the GCDC DC; maximal staining is observed within 6 hr of LPS upon activation. DC-LAMP, which is absent at immature stages ( Figure 7A ), appears in the MIIC at an intermediactivation and correlates with up-regulation of CD86, a ate stage of DC maturation (5-6 hr LPS) ( Figure 7B ). good marker of DC maturation. Interestingly, we found Again, after full maturation (24-96 hr LPS), all intracelluthat CD68, the gene most homologous to DC-LAMP, is lar MHC class II molecules are translocated to the cell expressed at an early stage of DC differentiation and is surface, and DC-LAMP is condensed into perinuclear down-regulated upon maturation on either monocytelysosomes coexpressing high levels of LAMP-1 (Figure and Soluble antigens captured by DC transit through the MIIC (Nijman et al., 1995) . We therefore performed a DC-LAMP Is Transiently Expressed in the MIIC FITC-Dextran uptake for 1 hr at 37ЊC on nonactivated To analyze the subcellular localization of DC-LAMP, we or for 6 hr on LPS-activated monocyte-derived DC. As have studied different stages of DC maturation by confoexpected, immature DC capture high levels of FITCcal microscopy. The DC-LAMP signal is absent or very Dextran but do not express DC-LAMP, while class II weak at the immature stage of CD34 ϩ -derived DC matumolecules are still intracellular ( Figures 8A and 8D ). After ration (day 10-11), when most of the MHC class II mole-6 hr of LPS activation, DC-LAMP appears and colocalcules are still intracellular and when the homologous izes with FITC-Dextran, establishing that DC-LAMP ϩ lysosomal marker, CD68, is highly expressed (Figure 6 ; vesicles intersect with the endosomal compartment. At data not shown). DC-LAMP appears first during "spontathis intermediate stage of maturation, DC-LAMP is presneous" maturation of DC (day 12) within vesicles spread ent in MHC class II ϩ vesicles ( Figure 7B ), which also throughout the whole cell that contain MHC class II contain HLA-DM ( Figure 8C ) and display an acidic pH molecules, LAMP-1, LAMP-2, CD68, cathepsin D, and revealed by the accumulation of the lysotracker mole-HLA-DM ( Figure 6 ; data not shown). These vesicles corcules ( Figure 8F ). Those observations are in agreement respond to the previously described MIIC (Peters et al., with the FACS data reported above. 1991). After CD40L activation, DC-LAMP accumulates Collectively, these results revealed that DC-LAMP apinto more central and larger vesicles, which are class pears transiently in the MIIC just before the translocation II exist for the characterization of DC subtypes. We report luminal domain, a single transmembrane region, and a short cytoplasmic tail of 10-11 amino acids (Fukuda, here the identification of a novel member of the LAMP family, called DC-LAMP, which is specifically expressed 1991). As for the other LAMP members, 90% of DC-LAMP protein should be located in the lumen of lysoby a subset of DC, the interdigitating dendritic cells (IDC). On the basis of sequence and domain homologies, somes, and the intraluminal portion can be divided in two domains by a serine/proline-rich hinge region (Fu-DC-LAMP is clearly a member of the LAMP family of lysosomal associated glycoproteins. Common struckuda et al., 1988) . DC-LAMP and CD68 share very similar predicted structure and are the only two members of tural features of this family include a molecular mass of 90-120 kDa, a polypeptide core of ‫04ف‬ kDa, a high this LAMP family with a single membrane-proximal (domain II) lamp-like domain, where the highly conserved number (7-20) of N-linked glycosylation sites in their cysteines form disulfide bounds that probably stabilize but, up to now, very few MAbs are truly DC specific. Immature, epithelial Langerhans cells are characterized the protein (Fukuda, 1991) . In their N-terminal portion (domain I), CD68 and DC-LAMP contain a region rich in by expression of CD1a (Fithian et al., 1981) , Lag (Kashihara et al., 1986) , and Langerin, a protein recently identiserines and threonines, which may bear O-linked glycan chains and is therefore considered as a mucin-like strucfied in our laboratory (unpublished data), but they lack DC-LAMP. In contrast, immunohistological analysis ture (Holness and Simmons, 1993) . Preliminary immunoprecipitation studies revealed that, like the other memshows DC-LAMP to be an IDC-specific marker. IDC are mature DC located in T cell areas of lymphoid tissues, bers of the family, DC-LAMP is highly glycosylated: the observed mass of the mature glycoprotein on SDScharacterized by a strong expression of MHC class II molecules, a low Ag uptake capacity, and a potent ability PAGE is around 70-90 kDa (data not shown), whereas the predicted mass for the polypeptide core is 44 kDa.
to stimulate naive T cells (Steinman, 1991) . They express a set of markers shared by other cells, including a high The extensive glycosylation of LAMP molecules is thought to be important for protecting the polypeptide level of MHC class II, CD80, CD86, and CD40, as well as CD83 (Zhou et al., 1992; Bjö rck et al., 1997) , and p55 cores from proteolytic degradation within the lysosome (Barriocanal et al., 1986) . Another conserved feature of (Mosialos et al., 1996) . The correlation between DC-LAMP expression and DC maturation was directly estab-LAMP molecules, a short cytoplasmic tail with a GY motif, essential for adressing the LAMP molecules to lished by in vitro studies. While DC-LAMP is absent in immature DC (day 8 CD34 ϩ -derived DC, monocytelysosomes, is also present in DC-LAMP Harter and Mellman, 1992) . Despite their derived DC), it is rapidly up-regulated (3-9 hr in monocyte-derived DC) upon maturation induced by TNF␣, structural homology and the high degree of conservation across different species, members of the LAMP family LPS, or CD40L. Moreover, detection of DC-LAMP correlates with strong expression of CD86 and surface MHC are located on different chromosomes: human LAMP-1, LAMP-2, CD68, and DC-LAMP are mapped on chromoclass II molecules, which are both features of the end stage of DC maturation. While DC-LAMP MAb stains somes 13q34, Xq24-25 (Mattei et al., 1990) , 17p13, and 3q26-27, (D.R. Greaves, personal communication), reexclusively IDC on tissue sections, a low level of DC-LAMP mRNA expression could be induced upon activaspectively. This suggests that these proteins diverged relatively early in the evolution, probably acquiring distion in vitro in other APC types (monocytes, macrophages, and B cells), further suggesting a role for this tinct functions. Of note, to date no monogenic human disease has been linked to any of the LAMP member novel lysosomal protein in antigen presentation. The tight control of DC-LAMP expression during DC loci.
DC express a repertoire of molecules common to maturation was confirmed by confocal microscopy, and a striking distribution of the molecule was observed. other leukocytes and a high level of MHC molecules, Early immature DC, which express most of their MHC in some circumstances DC-LAMP could play a similar role at the DC surface. The reciprocal expression of class II molecules intracellularly, could not be stained with anti-DC-LAMP MAb. DC-LAMP was first detected CD68 and DC-LAMP by DC suggests that despite their structural homology, these two molecules may serve at an intermediate maturation stage (6 hr LPS) within small intracellular vesicles spread through the cytodistinct functions. It has been proposed that through its mucin-like domain, CD68 could favor an efficient preplasm as well as within perinuclear lysosomes. At this stage of maturation, the peripheral DC-LAMP ϩ strucsentation by MHC class II molecules (Rabinowitz and Gordon, 1991; Holness and Simmons, 1993) . Moreover, tures represent acidic vesicles that intersect with the endosomal compartment and contain MHC class II molsurface CD68 binds oxidized low-density lipoprotein (Ramprasad et al., 1996) and shuttles rapidly between ecules and HLA-DM as well as lysosomal markers LAMP-1, LAMP-2, and CD68, to a weaker extent. Therethe endosomes and the plasma membrane. It also recognizes phosphatidyl-rich liposomes and may facilitate fore, DC-LAMP first appears in the so-called lysosomal MHC class II ϩ compartment (MIIC), which has been inithe capture of apoptotic bodies. Indeed, despite a very weak expression at the cell surface, the conserved Y tially described in human B cells (Peters et al., 1991) and, more recently, in immature DC (Nijman et al., 1995;  residue is likely to promote an efficient internalization of DC-LAMP (Harter and Mellman, 1992) . Pierre et al., 1997) . The MIIC is thought to be the site of efficient peptide loading on MHC class II molecules in
In conclusion, we have identified a novel member of the LAMP family, which represents a marker specific to human B cells (Rudensky et al., 1994; Tulp et al., 1994; West et al., 1994) . Thus, the appearance of DC-LAMP mature human dendritic cells. The presence of DC-LAMP in the MIIC in late mature DC indicates that this parallels the remodeling of the endosome/lysosome compartment observed during human DC maturation, may serve an important function during the processing of exogenous antigens. DC-LAMP might also participate reminiscent of a recently published study on mice by Pierre et al. (1997) . Of note, during hourly kinetic study in the functional remodeling of the MIIC by facilitating the translocation of MHC class II molecules to the cell of human monocyte-derived DC maturation (Figure 7 ; data not shown), we have been unable to detect by consurface. However, direct information about the role of DC-LAMP will await the analysis of mice deficient for focal microscopy the nonlysosomal class II PBMC and T cells were purified using standard protocols (Bates Increased proteolytic degradation of Ii by cathepsin faet al., 1997). B cells were obtained from human tonsils as described . Langerhans cells were prepared from normal skin vors the loading of peptides onto MHC class II (Cressby CD1a positive selection. A purity higher than 95% was systematiwell, 1998) molecules and the translocation of these cally achieved. Germinal center dendritic cells (GCDC) were premolecules to the cell surface. Whether the accumulation pared as previously described (Grouard et al., 1996) . The purity of of DC-LAMP protein in the peripheral MIIC and the pro-GCDC was higher than 97%. GCDC were stimulated either by PMAgressive disappearance of CD68 also participate in MHC ionomycin for 3 hr or by an anti-CD40 MAb (10 g/ml G28-5 MAb;
class II remodeling remains to be established. In any kindly provided by Ed. Clark, University of Washington, Seattle, WA) for 20 hr.
case, at later stages of DC maturation, the MIIC vanishes Granulocytes and macrophages were generated in vitro from as all the MHC class II molecules move to the cell surface lines stimulated by PMA-ionomycin for 1 and 6 hr were pooled.
LAMP-2 has been described as a receptor for selective
Murine fibroblasts transfected with human CD40 ligand (CD40L L uptake and degradation of cytoplasmic proteins within cells) were produced in the laboratory. All cell types were cultured lysosomes (Cuervo and Dice, 1996) . As only the GY in complete RPMI 1640 (GIBCO BRL, Gaithersburg, MD) (Caux et al., 1996) .
motif is conserved between the rat LAMP-2 cytosolic 12 amino acid sequence implicated in this uptake and DC-LAMP, it is unlikely that DC-LAMP will have a similar
Generation of DC from CD34 ؉ Cells and from Monocytes Isolation of CD34 ϩ progenitors from umbilical cord blood samples function. LAMP-1, LAMP-2, and CD68 are mostly found was achieved using Minimacs separation columns (Miltenyi Biotec in lysosomes, but they can also be detected at the cell GmbH, Bergish Gladbach, Germany) . Cultures of CD34 ϩ cells were surface, especially of tumor cells (Lippincott-Schwartz established in the presence of SCF, GM-CS,F and TNF␣ as deand Fambrough, 1987; Ramprasad et al., 1996) . Their scribed (Caux et al., 1996) . At day 12-17, 70%-90% of cells were highly glycosylated domain has been implicated in bind- , 1994) . It is unknown whether purified monocytes for 6 days in the presence of GM-CSF and IL-4 tonsil sections were also stained using mouse IgG1 anti-CD40 (MAb 89, produced in our laboratory), saturated for 10 min with 10% (Sallusto and Lanzavecchia, 1994) . Cells were activated with LPS (Sigma) at the concentration of 25 ng/ml for 1-72 hr.
mouse serum, and stained again using mouse anti-DC-LAMP-biotin. Skin sections were stained using mouse Ig2b anti-CD1a (Becton Dickinson, Mountain View, CA) together with anti-DC-LAMP. The cDNA Libraries and Isolation of the E02B02 cDNA Clone binding of mouse IgG1 antibodies was revealed by sheep antiTotal RNA was isolated from PMA-ionomycin activated CD1a ϩ mouse IgG1 (The Binding Site, Birmingham, UK), followed by incuba-CD14 Ϫ -derived DC (at day 12 of the culture) (Caux et al., 1996) tion with alkaline phosphatase coupled to mouse antibodies specific and from PMA-ionomycin-activated CHA cell line following standard for alkaline phosphatase (APAAP complexes, Dako). The binding of procedures. RNA was treated with DNase I before mRNA purification mouse IgG2a, IgG2b, and IgG3 antibodies were respectively reusing the Oligotex-dT kit (Qiagen GmbH, Hilden, Germany). PolyA ϩ vealed by biotinylated sheep anti-mouse IgG2a, IgG2b, and IgG3 RNA (2 g) was used to make a cDNA library in the pSport vector (The Binding Site), followed by ExtrAvidin-peroxidase (Sigma). Alka-(Superscript Plasmid System Kit, GIBCO BRL). A library subtraction line phosphatase activity was developed by the Fast Blue substrate cDNA was performed as described (Bates et al., 1997) . In this proto-(Sigma), whereas peroxydase activity was developed by 3-aminocol, the tracer (subtracted) was the CD1a ϩ -derived DC cDNA, and 9-ethylcarbazole (Sigma). the driver (subtractive) was CHA cDNA. A 0.7 kb cDNA containing a poly(A) tail was isolated from the CD1a ϩ -derived DC subtraction library.
Cytofluorimetric Analysis of Intracellular The full-length cDNA of this gene was amplified using the RACE and Cell Surface Phenotype Marathon kit (Clontech, Palo Alto, CA) and two oligonucleotides, 5Ј-For intracellular staining, cells were incubated with mouse IgG1 anti-TATTTGATGCCTTCATCTTTACAGCCCA (NGSP1) and 5Ј-CACTCAA DC-LAMP (10 g/ml) for 30 min at 4ЊC in the presence of permeabili-GAAAGAACAGTTGGTTAGCGA (GSP1), with the recommended cyzation medium (0.1% saponin and 1% SVF). After two washes, cells cling program 1. PCR products were cloned in the pCRII plasmid were incubated with FITC-goat anti-mouse Ig (Dako 32 P]dCTP, as described (Bates et al., 1997) . Multiple human Intracellular immunofluorescence staining was conducted as preadult and fetal tissue blots (Clontech) were similarly used. For RTviously described (Rovere et al., 1998) . On polylysin-coated cov-PCR, total RNA was reverse transcribed using random hexamer erslips, cells fixed for 15 min with 4% paraformaldehyde in PBS primers (Pharmacia, Upsalla, Sweden) and the Superscript RNase-H were washed twice in 10 mM glycine in PBS and twice in PBS reverse transcriptase (GIBCO BRL). PCR was performed in a DNA and permeabilized with 0.5% saponin-1% BSA-PBS for 30 min. thermal cycler (Perkin Elmer) for 35 cycles (1 min denaturation at Coverslips were incubated for 30 min at room temperature with 5 94ЊC, 1 min annealing at 60ЊC, and 2 min elongation at 72ЊC) with g/ml anti-LAMP-1 (Pharmingen), anti-HLA-DR (Becton Dickinson), Taq polymerase (gene Amp PCR reagents kit; Perkin Elmer Cetus).
anti-DC-LAMP, or anti-HLA-DM in permeabilization medium. Rabbit ␤-actin RT-PCR was used as control for the efficiency of the reacanti-HLA-DM was raised against a peptide encoding the cytotion. Sense (nucleotides 99-118, 5Ј-GCACGATGGCAGTCAAATGA) plasmic tail of the HLA-DM ␤ chain. and antisense (nucleotides 825-806, 5Ј-GAAGTATCTCCGAGGTGA After three washes, cells were incubated for 30 min with second-AA) primers were used to amplify E02B02. ary labeled antibodies (donkey anti-mouse coupled to Texas red or Cyanin 5 [Vector Laboratories, Burlingame, CA]), washed, incubated Production of Recombinant E02B02 and Generation of MAb with mouse preimmune serum for 30 min, washed again, postfixed Human recombinant E02B02 was expressed in E. coli as Ig fusion with 2% paraformaldehyde, incubated for 30 min with a second and alkaline phosphatase fusion proteins. A HindIII-XhoI fragment primary antibody coupled to biotin, rinsed, and labeled with fluoreswas derived from PCR with E02B02 cDNA as template. The fragment cein-conjugated streptavidin or with a second primary antibody diwas inserted into a modified form of pCDM8 (InVitrogen, Carlsbad, rectly coupled to fluorescein. Uptake of FITC-Dextran (Molecular CA). This vector had the pCDM8 XhoI-NotI region replaced with a Probes, Eugene, OR) was performed for 1 hr at 37ЊC before or after fragment encoding human immunoglobulin G1, Fc (residues 74-768 5 hr of LPS treatment. Fixed cells were labeled with HLA-DR and of EMBL accession X70421), or mature human placental alkaline DC-LAMP as above. Visualization of acid pH compartments was phosphatase without its C-terminal membrane attachment domain performed using the weakly basic amine lysotracker (Molecular (residues 301-1749 of EMBL accession U09661). Recombinant plasProbes) that selectively accumulates in low internal pH cellular commids were electroporated in COP5 cells, and after 5-7 days of culpartments. The cells were incubated with the lysotracker for 1 hr at ture, Ig fusion protein ‫05ف(‬ kDa) was purified from supernatant by 37ЊC and fixed. Coverslips were mounted onto glass slides with HiTrapA chromatography (Pharmacia, Upsalla, Sweden). E02B02-Fluoromount (Southern Biotechnology Associates, Birmingham, alkaline phosphatase recombinant fusion protein was purified by AL). Confocal microscopy was performed using the Confocal Laser DEAE anion exchange chromatography on a Zephyr-D silicium colScanning Microscopy TCS 4D (Leica Lasertechnik GmbH, Heidelumn (IBF Sepracor, Villeneuve, France).
berg, Germany) (Rovere et al., 1998) . Mouse monoclonal antibodies against E02B02 were generated in BALB/c mice as previously described (Fossiez et al., 1996) , with three successive intraperitoneal injections of Freund's adjuvant Acknowledgments (Sigma) and 1 g of purified E02B02 Ig fusion protein. Hybridoma supernatants were selected on E02B02-alkaline phosphatase transPreliminary results were presented at the Keystone Symposia on fected COP5. Antibody binding was revealed with peroxidase-conCellular and Molecular Biology of Dendritic Cells held in Santa Fe, jugated sheep anti-mouse IgG (Biosys, Compiè gne, France).
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